Cita APA

Tabernero, J., Grothey, A., Van Cutsem, E., Wasan, H., Yoshino, T., Desai, J., . . . Hong, Y. S. (2021). Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study.

Citación estilo Chicago

Tabernero, Josep, Axel Grothey, Eric Van Cutsem, Harpreet Wasan, Takayuki Yoshino, Jayesh Desai, Fortunato Ciardiello, Fotio Loupakis, y Yong Sang Hong. Encorafenib Plus Cetuximab As a New Standard of Care for Previously Treated BRAF V600E-mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses From the BEACON Study. 2021.

Cita MLA

Tabernero, Josep, et al. Encorafenib Plus Cetuximab As a New Standard of Care for Previously Treated BRAF V600E-mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses From the BEACON Study. 2021.